Compare Albemarle Corp. (ALB) vs ResMed Inc. (RMD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Albemarle Corp. vs ResMed Inc. — how do they compare? Albemarle Corp. trades at $129.99 (market cap $15.22B), while ResMed Inc. trades at $207.68 (market cap $31.88B). The key difference: ResMed Inc. is far larger — about 2.1× Albemarle Corp.'s market cap, and Albemarle Corp. pays the higher dividend (1.26%). Which is the better fit depends on your goals.
| ALB | RMD | |
|---|---|---|
Market Cap | $15.22B | $31.88B |
Sector | Basic Materials | Health |
52-Week High | $215.62 | $293.73 |
52-Week Low | $67.30 | $182.82 |
Enterprise Value | $18.24B | $31.06B |
Dividend Yield | 1.26% | 1.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
